Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Article
|
Albumin-bound paclitaxel in solid tumors: clinical development and future directionsDrug design, development and therapy, 2015, Vol.9 (default), p.3767-3777 [Peer Reviewed Journal]COPYRIGHT 2015 Dove Medical Press Limited ;COPYRIGHT 2015 Dove Medical Press Limited ;2015. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2015 Kundranda and Niu. This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution – Non Commercial (unported, v3.0) License 2015 ;ISSN: 1177-8881 ;EISSN: 1177-8881 ;DOI: 10.2147/dddt.s88023 ;PMID: 26244011Full text available |
|
2 |
Material Type: Article
|
Dostarlimab for Primary Advanced or Recurrent Endometrial CancerThe New England journal of medicine, 2023-06, Vol.388 (23), p.2145-2158 [Peer Reviewed Journal]Copyright © 2023 Massachusetts Medical Society. All rights reserved. ;Copyright © 2023 Massachusetts Medical Society. ;ISSN: 0028-4793 ;ISSN: 1533-4406 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa2216334 ;PMID: 36972026Full text available |
|
3 |
Material Type: Article
|
Stellarex Drug-Coated Balloon for Treatment of Femoropopliteal Disease: Twelve-Month Outcomes From the Randomized ILLUMENATE Pivotal and Pharmacokinetic StudiesCirculation (New York, N.Y.), 2017-09, Vol.136 (12), p.1102-1113 [Peer Reviewed Journal]2017 by the American College of Cardiology Foundation and the American Heart Association, Inc. ;2017 The Authors. ;2017 The Authors. 2017 ;ISSN: 0009-7322 ;EISSN: 1524-4539 ;DOI: 10.1161/CIRCULATIONAHA.117.028893 ;PMID: 28729250Full text available |
|
4 |
Material Type: Article
|
Nanoparticle albumin-bound paclitaxel as neoadjuvant chemotherapy of breast cancer: a systematic review and meta-analysisOncotarget, 2017-03, Vol.8 (10), p.17360-17372Copyright: © 2017 Zong et al. 2017 ;ISSN: 1949-2553 ;EISSN: 1949-2553 ;DOI: 10.18632/oncotarget.14477 ;PMID: 28061451Full text available |
|
5 |
Material Type: Article
|
Inhibition of Glioma Cells' Proliferation by Doxorubicin-Loaded Exosomes via MicrofluidicsInternational journal of nanomedicine, 2020-01, Vol.15, p.8331-8343 [Peer Reviewed Journal]2020 Thakur et al. ;COPYRIGHT 2020 Dove Medical Press Limited ;2020. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2020 Thakur et al. 2020 Thakur et al. ;ISSN: 1178-2013 ;ISSN: 1176-9114 ;EISSN: 1178-2013 ;DOI: 10.2147/IJN.S263956 ;PMID: 33149579Full text available |
|
6 |
Material Type: Article
|
An Imagable and Photothermal "Abraxane-Like" Nanodrug for Combination Cancer Therapy to Treat Subcutaneous and Metastatic Breast TumorsAdvanced materials (Weinheim), 2015-02, Vol.27 (5), p.903-910 [Peer Reviewed Journal]2014 WILEY‐VCH Verlag GmbH & Co. KGaA, Weinheim ;2014 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim. ;ISSN: 0935-9648 ;EISSN: 1521-4095 ;DOI: 10.1002/adma.201404308 ;PMID: 25504416Full text available |
|
7 |
Material Type: Article
|
NK105, a paclitaxel-incorporating micellar nanoparticle formulation, can extend in vivo antitumour activity and reduce the neurotoxicity of paclitaxelBritish journal of cancer, 2005-04, Vol.92 (7), p.1240-1246 [Peer Reviewed Journal]Copyright Nature Publishing Group Apr 11, 2005 ;Copyright © 2005 Cancer Research UK 2005 Cancer Research UK ;ISSN: 0007-0920 ;EISSN: 1532-1827 ;DOI: 10.1038/sj.bjc.6602479 ;PMID: 15785749 ;CODEN: BJCAAIFull text available |
|
8 |
Material Type: Article
|
Phase II study of nab‐paclitaxel + carboplatin for patients with non‐small‐cell lung cancer and interstitial lung diseaseCancer science, 2019-12, Vol.110 (12), p.3738-3745 [Peer Reviewed Journal]2019 The Authors. published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association. ;2019 The Authors. Cancer Science published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association. ;2019. This work is published under http://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1347-9032 ;EISSN: 1349-7006 ;DOI: 10.1111/cas.14217 ;PMID: 31608537Full text available |
|
9 |
Material Type: Article
|
Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast CancerThe New England journal of medicine, 2018-11, Vol.379 (22), p.2108-2121 [Peer Reviewed Journal]Copyright © 2018 Massachusetts Medical Society. All rights reserved. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1809615 ;PMID: 30345906Full text available |
|
10 |
Material Type: Article
|
Phase I study of weekly nab-paclitaxel plus carboplatin and concurrent thoracic radiotherapy in elderly patients with unresectable locally advanced non-small cell lung cancerInvestigational new drugs, 2022-02, Vol.40 (1), p.106-114 [Peer Reviewed Journal]The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2021 ;2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature. ;The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2021. ;ISSN: 0167-6997 ;EISSN: 1573-0646 ;DOI: 10.1007/s10637-021-01155-w ;PMID: 34495421Full text available |
|
11 |
Material Type: Article
|
In vitro and in vivo anticancer effect of pH-responsive paclitaxel-loaded niosomesJournal of materials science. Materials in medicine, 2021-12, Vol.32 (12), p.147-13, Article 147 [Peer Reviewed Journal]The Author(s) 2021 ;2021. The Author(s). ;The Author(s) 2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 0957-4530 ;EISSN: 1573-4838 ;DOI: 10.1007/s10856-021-06623-6 ;PMID: 34862910Full text available |
|
12 |
Material Type: Article
|
Taxol ® : The First Microtubule Stabilizing AgentInternational journal of molecular sciences, 2017-08, Vol.18 (8), p.1733 [Peer Reviewed Journal]Copyright MDPI AG 2017 ;2017 by the authors. 2017 ;ISSN: 1422-0067 ;ISSN: 1661-6596 ;EISSN: 1422-0067 ;DOI: 10.3390/ijms18081733 ;PMID: 28792473Full text available |
|
13 |
Material Type: Article
|
Synthesis and evaluation of a paclitaxel-binding polymeric micelle for efficient breast cancer therapyScience China. Life sciences, 2018-04, Vol.61 (4), p.436-447 [Peer Reviewed Journal]Science China Press and Springer-Verlag GmbH Germany, part of Springer Nature 2018 ;Science China Life Sciences is a copyright of Springer, (2018). All Rights Reserved. ;ISSN: 1674-7305 ;EISSN: 1869-1889 ;DOI: 10.1007/s11427-017-9274-9 ;PMID: 29572777Full text available |
|
14 |
Material Type: Article
|
Liposome Encapsulated Albumin-Paclitaxel Nanoparticle for Enhanced Antitumor EfficacyPharmaceutical research, 2015-03, Vol.32 (3), p.1002-1016 [Peer Reviewed Journal]Springer Science+Business Media New York 2014 ;Springer Science+Business Media New York 2015 ;ISSN: 0724-8741 ;EISSN: 1573-904X ;DOI: 10.1007/s11095-014-1512-2 ;PMID: 25213777Full text available |
|
15 |
Material Type: Article
|
Combination Therapies to Improve the Efficacy of Immunotherapy in Triple-negative Breast CancerMolecular cancer therapeutics, 2023-11, Vol.22 (11), p.1304-1318 [Peer Reviewed Journal]2023 The Authors; Published by the American Association for Cancer Research. ;2023 The Authors; Published by the American Association for Cancer Research 2023 American Association for Cancer Research ;ISSN: 1535-7163 ;ISSN: 1538-8514 ;EISSN: 1538-8514 ;DOI: 10.1158/1535-7163.MCT-23-0303 ;PMID: 37676980Full text available |
|
16 |
Material Type: Article
|
Pembrolizumab plus Chemotherapy in Advanced Endometrial CancerThe New England journal of medicine, 2023-06, Vol.388 (23), p.2159-2170 [Peer Reviewed Journal]Copyright © 2023 Massachusetts Medical Society. All rights reserved. ;Copyright © 2023 Massachusetts Medical Society. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa2302312 ;PMID: 36972022Full text available |
|
17 |
Material Type: Article
|
SOX8 Affects Tumoral SPARC Expression by Regulating EZH2 to Attenuate Effectiveness of albumin-bound paclitaxel in PDACInternational journal of biological sciences, 2022, Vol.18 (3), p.911-922 [Peer Reviewed Journal]The author(s). ;2022. This work is published under https://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The author(s) 2022 ;ISSN: 1449-2288 ;EISSN: 1449-2288 ;DOI: 10.7150/IJBS.64752 ;PMID: 35173526Full text available |
|
18 |
Material Type: Article
|
Pembrolizumab versus paclitaxel for previously treated, advanced gastric or gastro-oesophageal junction cancer (KEYNOTE-061): a randomised, open-label, controlled, phase 3 trialThe Lancet (British edition), 2018-07, Vol.392 (10142), p.123-133 [Peer Reviewed Journal]2018 Elsevier Ltd ;Copyright © 2018 Elsevier Ltd. All rights reserved. ;2018. Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(18)31257-1 ;PMID: 29880231Full text available |
|
19 |
Material Type: Article
|
Paclitaxel balloon coating, a novel method for prevention and therapy of restenosisCirculation (New York, N.Y.), 2004-08, Vol.110 (7), p.810-814 [Peer Reviewed Journal]ISSN: 0009-7322 ;EISSN: 1524-4539 ;DOI: 10.1161/01.CIR.0000138929.71660.E0 ;PMID: 15302790Full text available |
|
20 |
Material Type: Article
|
Carboplatin and Paclitaxel for Advanced Endometrial Cancer: Final Overall Survival and Adverse Event Analysis of a Phase III Trial (NRG Oncology/GOG0209)Journal of clinical oncology, 2020-11, Vol.38 (33), p.3841-3850 [Peer Reviewed Journal]2020 by American Society of Clinical Oncology 2020 American Society of Clinical Oncology ;ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/jco.20.01076 ;PMID: 33078978Full text available |